Analpram HC NDC 54766-829

NDC codes

FDA NDC Directory

Product NDC (as listed)54766-829Labeler and product segments. Claims need a package NDC.

Product NDC at billing width54766-0829Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
54766-829-04	54766082904	59 mL in 1 BOTTLE, PLASTIC (54766-829-04)Marketed from Aug 5, 2015

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Analpram HC
Generic name (nonproprietary): hydrocortisone acetate and pramoxine hydrochloride
Active ingredients: Hydrocortisone acetate — 25 mg/mLPramoxine hydrochloride — 10 mg/mL
Dosage form: Lotion
Route: Topical
Labeler: Sebela Pharmaceuticals Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 085979
Marketing start: Aug 5, 2015
Marketing end: Mar 28, 2027
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 54766-829_431483ef-821d-1ef3-e063-6394a90ad31eSPL ID 431483ef-821d-1ef3-e063-6394a90ad31eSPL set ID 1469733e-1723-4b8c-be33-ed8dfafd65e2RxCUI 1234512, 1360956UNII 3X7931PO74, 88AYB867L5
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N454766082904 followed by a unit qualifier and the quantity

Package 54766-0829-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 8, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE: Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 085979

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 085979
Product	Strength	Form · route	Labeler	Product NDC
Pramosonehydrocortisone acetate and pramoxine hydrochloride	Hydrocortisone acetate 25 mg/mL; Pramoxine hydrochloride 10 mg/mL	LotionTopical	Legacy Pharma USA Inc.	83107-021
Analpram HChydrocortisone acetate and pramoxine hydrochloride	Hydrocortisone acetate 25 mg/g; Pramoxine hydrochloride 10 mg/g	CreamTopical	Legacy Pharma USA Inc.	83107-019
Analpram HChydrocortisone acetate and pramoxine hydrochloride	Hydrocortisone acetate 25 mg/mL; Pramoxine hydrochloride 10 mg/mL	LotionTopical	Legacy Pharma USA Inc.	83107-020